Browse services by

Browse by Model Type

PDX

Solid Tumor PDX
Blood Cancer PDX
Pretreated PDX
PDX Model Bank

CDX

CDX Models
CDX Model Bank

Ex Vivo

Hematological Cancer Screen
3D Solid Tumor Models

Syngeneic Models

Humanized Models

Browse by Tumor Type

Solid Tumors

PDX Models
Ex Vivo Models
CDX
Syngeneic

Hematologic Malignancies

PDX Models
Ex Vivo Models
CDX

Browse by Modality/Target

Modalities

Radiopharmaceuticals

Targets

KRAS

ADC

Browse by Application

In Vivo Screening (Mouse Clinical Trials)

TMAs
Mechanism of Resistance
HT-RNA-Seq

Ex Vivo Hematological Cancer Screen

Ex Vivo Solid Tumor Screening

Co-Culture Assays

Analytical Assays

Flow Cytometry

Histology / IHC

ELISA / Luminex

Next Generation Sequencing

4D Proteomics

Western Blot

DNA Damage Assays

Colony Forming Unit (CFU) Assay

Imaging

Cell Viability & Proliferation

Quantitative PCR

NEW CAPABILITY

In-house SPECT/CT imaging

See where your radiopharmaceutical goes and when, with longitudinal SPECT/CT in our own lab.

Explore radiopharma

Data Ecosystem

Data Platform

Cell Surface Proteomics

KRAS-Mutant Atlas

The Dataset

Lumin

Resource Library

Blog

Case Studies

Events

Flow Cytometry Panels

Infographics

Model Spotlights

PDX Model Cohorts

Posters

Press Releases

Publications

Research Platforms

Webinars

White Papers

Company

Who We Are

History

Mission & Values

Corporate Citizenship

Leadership Team

Board of Directors

Strategic Partnerships

Careers

Investors

Investor Relations

Press Releases

Select Models

PDX Select

Model Bank

Search through our extensive and highly characterized PDX bank.

Model ID

Acute lymphoblastic leukemia (ALL) 0 Acute myeloid leukemia (AML) 0 Adenoid cystic carcinoma 0 Adrenal gland 0 Adrenocortical carcinoma 0 Ampullary 0 Anaplastic ganglioglioma 0 Appendiceal 0 Bladder 0 Breast 0 Breast (organoid) 0 Cervical 0 Cholangiocarcinoma 0 Chordoma 0 Chronic lymphocytic leukemia (CLL) 0 Colorectal 0 Duodenal 0 Endometrial 0 Esophageal 0 ETANTR 0 Fallopian tube 0 Gallbladder 0 Gastric 0 Germ cell 0 Glioblastoma multiforme (GBM) 0 Glioma (other than GBM) 0 Head and neck 0 Hepatoblastoma 0 Hepatocellular carcinoma (HCC) 0 Lung 0 Lymphoma 0 Mantle cell lymphoma (MCL) 0 Medulloblastoma 0 Melanoma 0 Merkel cell 0 Mesothelioma 0 Myoepithelioma 0 Neuroendocrine tumor 0 NSCLC 0 Other 0 Ovarian 0 Pancreatic 0 Peritoneal carcinoma 0 Perivascular epithelioid cell tumor (PEComa) 0 Prostate 0 Rectal 0 Renal cell carcinoma 0 Sacrococcygeal teratoma 0 Sarcoma 0 SCLC 0 Sialoblastoma 0 Small intestinal/Small bowel 0 Testicular 0 Thymic 0 Thymoma 0 Thyroid 0 Unknown origin 0 Uterine 0 Uveal melanoma 0 Vulvar 0

Primary 0 Local metastatic 0 Metastatic 0 Pending 0 Not available 0

Naive 0 Pretreated 0 Pending 0 Not Available 0

I 0 II 0 III 0 IV 0 Not Available 0 Pending 0

WES 0 RNA-Seq 0 Proteomics 0

Clear all filters

1393 models

page 59 of 59

CTG-4525 Breast Invasive ductal carcinoma Tumor status Metastatic Treatment history Pretreated Harvest site Liver Disease stage IV View model →

← Previous

page 59 of 59

Let's build the right study, together.

Backed by deep expertise in these models, our team will work with you to design the study around your target, line of therapy, and endpoint.

Corporate Headquarters

One University Plaza, Suite 307 Hackensack, NJ 07601, USA

USA Research Operations

1330 Piccard Drive, Suite 025 & Suite 104 Rockville, MD 20850, USA

Bioinformatics & Computational Biology

4 Oppenheimer St., Ha'ogen Building B Rehovot 7670104, Israel